Liver in the limelight in the corona (COVID-19) time
| Autor: | Syed Bilal Pasha, Ebubekir Daglilar, Harleen K. Chela, Veysel Tahan, Omer Basar |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Gastrointestinal Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) medicine.disease_cause Virus law.invention Pathogenesis 03 medical and health sciences Liver disease 0302 clinical medicine law Medicine Intensive care medicine Coronavirus Limelight business.industry SARS-CoV-2 COVID-19 Minireviews General Medicine medicine.disease Review article Liver 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology business Angiotensin converting enzyme 2 enzyme |
| Zdroj: | World Journal of Clinical Cases |
| ISSN: | 2307-8960 |
| Popis: | The novel coronavirus, severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2), is a topic of great interest currently in the medical field due to the significant morbidity and mortality associated with it. There is immense curiosity about this virus as knowledge about it is limited from pathogenesis, host related factors and the variable effect it has on different patient populations. Though it has claimed fame due to its ability to compromise the respiratory system, it possess the capability to infect other organs as well including the liver. It is important for clinicians to recognize that the virus can result in multi-organ dysfunction as well. Presentation with gastrointestinal symptoms and involvement of the liver can be subtle and can be misdiagnosed. Those with pre-existing liver disease may be more susceptible as well as those who are immunosuppressed or have other co-morbidities. This review article provides a brief overview of some of the information that is available so far with regards to how the liver is impacted by the coronavirus. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|